scispace - formally typeset
M

Mei Xin

Researcher at Cincinnati Children's Hospital Medical Center

Publications -  42
Citations -  4671

Mei Xin is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Medicine & Oligodendrocyte. The author has an hindex of 22, co-authored 32 publications receiving 3768 citations. Previous affiliations of Mei Xin include University of Texas at Dallas & University of Texas Southwestern Medical Center.

Papers
More filters
Journal ArticleDOI

Hippo pathway effector Yap promotes cardiac regeneration

TL;DR: It is reported that mice bearing mutant alleles of Yap and its paralog WW domain containing transcription regulator 1 (Taz) exhibit gene dosage-dependent cardiac phenotypes, suggesting redundant roles of these Hippo pathway effectors in establishing proper myocyte number and maintaining cardiac function.
Journal ArticleDOI

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.

TL;DR: MiR-143 and miR-145 act as integral components of the regulatory network whereby SRF controls cytoskeletal remodeling and phenotypic switching of SMCs during vascular disease.
Journal ArticleDOI

Regulation of Insulin-Like Growth Factor Signaling by Yap Governs Cardiomyocyte Proliferation and Embryonic Heart Size

TL;DR: Yap is shown to be a critical downstream effector of the Hippo pathway in the control of cardiomyocyte proliferation and a nexus for coupling the IGF, Wnt, and Hippo signaling pathways with the developmental program for heart growth.
Journal ArticleDOI

Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair

TL;DR: Stimulating cardiomyocyte dedifferentiation and proliferation by activating mitotic signalling pathways involved in embryonic heart growth represents a complementary approach for heart regeneration and repair.